Presents a review of literature related to secondary acute myelogenous leukemia (AML). AML caused by exposure to genotoxic agents; Secondary AML following treatment with alkylating agents; Topoisomerase-associated secondary AML; DNA damage and repair; Molecular epidemiology; Longitudinal monitoring of high-risk populations.